Variant report
Variant | nsv967018 |
---|---|
Chromosome Location | chr3:68684918-68687051 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr3:68684892-68684998 | GM20000 | blood: | n/a | n/a |
2 | CTCF | chr3:68685637-68685680 | GM10248 | blood: | n/a | n/a |
3 | CTCF | chr3:68685975-68686110 | GM10266 | blood: | n/a | n/a |
4 | CTCF | chr3:68684940-68684989 | Kidney_OC | kidney: | n/a | n/a |
5 | CTCF | chr3:68685207-68685275 | GM20000 | blood: | n/a | n/a |
6 | POLR2A | chr3:68685242-68685253 | Hela-S3 | cervix: | n/a | n/a |
7 | POLR2A | chr3:68685921-68685988 | HepG2 | liver: | n/a | n/a |
8 | POLR2A | chr3:68685907-68685921 | A549 | lung: | n/a | n/a |
9 | POLR2A | chr3:68685838-68685871 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr3:68685465-68686104 | GM12878 | blood: | n/a | n/a |
11 | POLR2A | chr3:68685526-68686026 | GM12878 | blood: | n/a | n/a |
12 | POLR2A | chr3:68685856-68686353 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | POLR2A | chr3:68685218-68685420 | ProgFib | skin: | n/a | n/a |
14 | POLR2A | chr3:68685902-68686058 | GM12878 | blood: | n/a | n/a |
15 | POLR2A | chr3:68685665-68685722 | HepG2 | liver: | n/a | n/a |
16 | POU2F2 | chr3:68685050-68685505 | GM12878 | blood: | n/a | n/a |
17 | USF1 | chr3:68685135-68685329 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000244640 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11557330 | chr3:68684975-68684976 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs564013047 | chr3:68684997-68684998 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs529508068 | chr3:68685010-68685011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543271770 | chr3:68685030-68685031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559475174 | chr3:68685045-68685046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570103330 | chr3:68685067-68685068 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs528160429 | chr3:68685104-68685105 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs184532291 | chr3:68685110-68685111 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs373012592 | chr3:68685115-68685116 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs571181376 | chr3:68685152-68685153 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs530463000 | chr3:68685171-68685172 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs550456151 | chr3:68685182-68685183 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs376290763 | chr3:68685187-68685188 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs17028372 | chr3:68685200-68685201 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs111274780 | chr3:68685220-68685221 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs567248976 | chr3:68685221-68685222 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs536020997 | chr3:68685252-68685253 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs552712578 | chr3:68685258-68685259 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs370196808 | chr3:68685284-68685285 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs112782828 | chr3:68685287-68685288 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs566573993 | chr3:68685291-68685292 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs572144537 | chr3:68685314-68685315 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs2047891 | chr3:68685326-68685327 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs535074464 | chr3:68685341-68685342 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs557982191 | chr3:68685395-68685396 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs577963616 | chr3:68685425-68685426 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs55751721 | chr3:68685490-68685491 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs143085341 | chr3:68685499-68685500 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs376311952 | chr3:68685512-68685513 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs557666958 | chr3:68685562-68685563 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs372739746 | chr3:68685564-68685565 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs543358995 | chr3:68685574-68685575 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs559938597 | chr3:68685618-68685619 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs376441291 | chr3:68685626-68685627 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs573365643 | chr3:68685668-68685669 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs148208291 | chr3:68685670-68685671 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs564875829 | chr3:68685673-68685674 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs530502320 | chr3:68685691-68685692 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs550194458 | chr3:68685692-68685693 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs140115566 | chr3:68685710-68685711 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs56212096 | chr3:68685713-68685714 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs150288366 | chr3:68685719-68685720 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs546496352 | chr3:68685737-68685738 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs566622442 | chr3:68685775-68685776 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs538499036 | chr3:68685798-68685799 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs551852172 | chr3:68685804-68685805 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs571678826 | chr3:68685826-68685827 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs187618443 | chr3:68685843-68685844 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs557359196 | chr3:68685849-68685850 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs574085457 | chr3:68685853-68685854 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:68683600-68693400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr3:68686400-68686800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr3:68686400-68687400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |